Companies / Imagene
Imagene
Company
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases.
Imagene has 2 investors on file, among them Atlas Venture and Omega Funds.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Atlas Venture
52 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (93%), Industrial & Manufacturing (2%), Robotics & Hardware (2%).
More from Omega Funds
86 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (84%), Fintech (2%), AI & Machine Learning (2%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Imagene and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atlas Venture adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/ikenaoncology.com/investors
# also
GET /v1/companies/ikenaoncology.com
GET /v1/companies/ikenaoncology.com/news